Helius Medical Technologies, Inc. (NASDAQ:HSDT) Short Interest Up 7.0% in August

Helius Medical Technologies, Inc. (NASDAQ:HSDT) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 33,500 shares, a growth of 7.0% from the August 15th total of 31,300 shares. Based on an average daily volume of 224,300 shares, the short-interest ratio is currently 0.1 days.

Hedge Funds Weigh In On Helius Medical Technologies

An institutional investor recently bought a new position in Helius Medical Technologies stock. Armistice Capital LLC purchased a new stake in Helius Medical Technologies, Inc. (NASDAQ:HSDT) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 130,000 shares of the company’s stock, valued at approximately $127,000. Armistice Capital LLC owned approximately 4.39% of Helius Medical Technologies as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 18.63% of the company’s stock.

Helius Medical Technologies Trading Down 2.5 %

Shares of Helius Medical Technologies stock opened at $0.80 on Thursday. The business has a 50-day moving average price of $0.78 and a two-hundred day moving average price of $2.39. Helius Medical Technologies has a 1-year low of $0.65 and a 1-year high of $10.99. The company has a market cap of $2.38 million, a P/E ratio of -0.06 and a beta of 1.61.

Helius Medical Technologies (NASDAQ:HSDT) last issued its quarterly earnings results on Monday, August 12th. The company reported ($0.64) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.14). The business had revenue of $0.18 million for the quarter. Helius Medical Technologies had a negative return on equity of 258.06% and a negative net margin of 1,487.54%. During the same period in the prior year, the firm posted ($3.00) EPS.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.